期刊文献+

特异性miRNA-200b抑制剂对肝星状细胞生物学特性的影响 被引量:2

Effect of miRNA-200b-specific inhibitor on biological characteristics of rat hepatic stellate cells
原文传递
导出
摘要 目的 观察特异性miRNA-200b抑制剂对肝星状细胞增殖、活化、胶原合成的影响.方法 设计并合成miR-200b抑制剂,利用脂质体将miRNA-200b抑制剂转入肝星状细胞中,培养48 h后,收集肝星状细胞和上清液,采用qRT-PCR探针的方法检测miR-200b的表达水平、Westernblotting检测细胞α-平滑肌肌动蛋白(α-SMA)表达、噻唑蓝(MTT)法检测细胞增殖活性和放射免疫法检测培养上清液中Ⅲ型前胶原和透明质酸含量.结果 与阴性对照组相比,miRNA-200b抑制剂转染48 h后HSC-T6细胞miR-200b组表达下调82%;α-SMA蛋白表达降低(19±3)%(P<0.05);细胞增殖活性降低(33±5)%(P<0.01);培养上清中Ⅲ型前胶原和透明质酸含量分别降低(35±4)%和(31±2)%(均P <0.01).结论 miRNA-200b抑制剂下调HSC-T6细胞中miR-200b表达,抑制肝星状细胞增殖与活化,减少细胞外基质的合成和分泌. Objective To investigate the effect of miRNA-200b-specific inhibitor on hepatic stellate cells(HSCs) activation,proliferation,and extracellular matrix production.Methods The miRNA-200b-specific inhibitors were designed,synthesized,and transfected into HSCs with lipofectamine 2000.The supernatant and HSCs were collected after incubation for 48 h.The expression of miR-200b was detected by quantitative reverse transcription polymerase chain reaction (qRT-PCR).The expression ofα-smooth muscle actin (oα-SMA) protein in HSCs was detected by Western blotting.The cell proliferation was assayed by methyl thiazolyl tetrazolium (MTT) method.Contents of type Ⅲ procollagen and hyaluronic acid in supernatant were determined by radioimmunoassay.Results Compared to the control group,miRNA-200b expression was decreased in the miRNA-200b inhibitor group by 82% (P 〈 0.01),α-SMA protein expression was reduced in the miRNA-200b inhibitor group by (19 ± 3) % (P 〈 0.05),and the activity of HSCs proliferation was reduced by(33 ± 5)% (P 〈0.01),and the contents of type Ⅲ procollagen and hyaluronic acid in supernatant were reduced in miRNA-200b inhibitor group by (35 ± 4)% and (31 ± 2)%,respectively(P 〈0.01).Conclusions The miRNA-200b-specific inhibitor could significantly reduce the expression of miRNA-200b,and inhibit HSC proliferation,activation,and extracellular matrix production.
出处 《中国医师杂志》 CAS 2015年第5期682-684,688,共4页 Journal of Chinese Physician
基金 浙江省自然科学基金资助项目(LY14H030010) 温州市科技局资助项目(Y20120032)
关键词 微RNAs/拮抗剂和抑制剂/药理学/代谢 肝细胞/细胞学/药物作用 星形细胞/药物作用 细胞增殖/药物作用 胶原/代谢 肌动蛋白类/代谢 透明质酸/代谢 MicroRNAs/AI/PD/ME Hepatocytes/CY/DE Astrocytes/DE Cell proliferation/DE Collagen/ME Actins/ME Hyaluronic acid/ME
  • 相关文献

参考文献7

  • 1Novo E, Cannito S, Patemostro C, et al. Cellular and molecular mechanisms in liver fibrogenesis [ J ]. Arch Biochem Biophys, 2014,548:20-37.
  • 2Xin X, Zhang Y, Liu X, et al. MicroRNA in hepatic fibrosis and cirrhosis [ J ]. Front Biosci ( landmark Ed ) , 2014, 19 : 1418- 1424.
  • 3He Y, Huang C, Lin X, et al. MicroRNA-29 family, a crucial therapeutic target for fibrosis diseases [ J ]. Biochimie, 2013,95 (7) :1355-1359.
  • 4Lakner AM, Steuerwald NM, Walling TL, et al. Inhibitory effects of microRNA 19b in hepatic stellate cell-mediated fibrogenesis [ J]. Hepatology, 2012,56( 1 ) :300-310.
  • 5Tang O, Chen XM, Shen S, et al. MiRNA-200b represses trans- forming growth factor-l-induced EMT and fibronectin expression in kidney proximal tubular cells [ J ]. Am J Physiol Renal Physiol, 2013,304(10) :F1266-F1273.
  • 6Chu CM, Shyu WC, Liaw YF. Comparative studies on expression of alpha- smooth muscle actin in hepatic stellate ceils in chronic hepatitis B and C[J]. Dig Dis Sci, 2008, 53(5) :1364-1369.
  • 7俞富军,董培红,范栩妃,陈永平,李骥.脂联素抑制大鼠肝星状细胞株HSC-T6的Ⅲ型前胶原和透明质酸的表达[J].中国医师杂志,2011,13(2):150-153. 被引量:2

二级参考文献12

  • 1Wynn TA. Cellular and molecular mechanisms of fibrosis. J Pathol, 2008,214(2) :199-210.
  • 2Nam JS, Park JS, Cho MH, et al. The association between pulse wave velocity and metabolic syndrome and adiponectin in patients with impaired fasting glucose: cardiovascular risks and adiponectin in IFG. Diabetes Res Clin Pract ,2009,84 (2) :145-151.
  • 3Savvidou S, Hytiroglou P, Orfanou-Koumerkeridou H, et al. Low se- rum adiponectin levels are predictive of advanced hepatic fibrosis in patients with NAFLD. J Clin Gastroenterol,2009,43 (8) :765- 772.
  • 4Polyzos SA, Kountouras J, Zavos C, et al. The role of adiponectin in the pathogenesis and treatment of non-alcoholic fatty liver disease. Diabetes Obes Metab ,2010,12 ( 5 ) : 365-383.
  • 5Asano T,Watanabe K, Kubota N,et al. Adiponectin knockout mice on high fat diet develop fibrosing steatohepatitis. J Gastroenterol Hepato1,2009 ,24(10) : 1669-1676.
  • 6Moreira RK. Hepatic stellate cells and liver fibrosis. Arch Pathol Lab Med ,2007,131 ( 11 ) :1728- 1734.
  • 7Parsons C J, Takashima M, Rippe RA. Molecular mechanisms of hepatic fibrogenesis. J Gastroenterol Hepatol, 2007,22 ( Suppl 1 ) : S79 -84.
  • 8Krawczyk K, Szczesniak P, Kumor A, et al. Adipohormones as prognostric markers in patients with nonalcoholic steatohepatitis (NASH). J Physiol Pharmaco1,2009,60 ( Suppl 3 ) :71-75.
  • 9Huang H,Park PH,McMullen MR,et al. ,Mechanisms for the anti-inflammatory effects of adiponectin in macrophages. J Gastroen- terol Hepatol,2008,23 (Suppl 1 ) :S50-53.
  • 10Adachi M, Brenner DA. High molecular weight adiponectin inhib- its proliferation of hepatic stellate cells via activation of adenosine monophosphate-activated protein kinase. Hepatology, 2008,47 (2) :677-685.

共引文献1

同被引文献24

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部